PPF reshuffles Autolus (NASDAQ: AUTL) stake without trimming exposure

Rhea-AI Filing Summary

Autolus Therapeutics plc (AUTL) received an amended Schedule 13D (Amendment No. 11) from a group of Czech- and Cyprus-based investors led by Renata Kellnerova and affiliated PPF entities. The filing reports that PPF IM Ltd. is now the owner of record of 14,782,275 ordinary shares, representing 5.6% of Autolus’s outstanding ordinary shares, based on 266,162,540 shares outstanding as of August 10, 2026.

The shares were moved in an internal reorganization via an intercompany transfer from PPF Biotech B.V. to PPF IM, completed on August 27, 2026, using PPF IM working capital and priced at the prior-day closing price. The group states that the reorganization did not change the ultimate beneficial ownership or voting/dispositive power over the shares and was not undertaken to change or influence control of Autolus. Other than this internal transfer, the reporting persons disclose no transactions in Autolus shares in the last 60 days.

Key Figures

Ordinary Shares Beneficially Owned: 14,782,275 ordinary shares Percent of Class: 5.6% Shares Outstanding: 266,162,540 shares +3 more

6 metrics

Ordinary Shares Beneficially Owned 14,782,275 ordinary shares Owned of record by PPF IM Ltd. as of Amendment No. 11

Percent of Class 5.6% Portion of Autolus outstanding ordinary shares represented by 14,782,275 shares

Shares Outstanding 266,162,540 shares Autolus ordinary shares outstanding as of August 10, 2026

Shared Voting Power 14,782,275 shares Reported shared voting power for each reporting person

Shared Dispositive Power 14,782,275 shares Reported shared dispositive power for each reporting person

Reorganization Completion Date August 27, 2026 Completion date of the internal reorganization and intercompany transfer

Key Terms

beneficial ownership, dispositive power, intercompany transfer, internal reorganization, +2 more

6 terms

beneficial ownership financial

"each may be deemed to directly or indirectly beneficially own such shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

dispositive power financial

"ultimate voting or dispositive power over, the Ordinary Shares reported herein"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

intercompany transfer financial

"were transferred by PPF Biotech B.V. to PPF IM by way of an intercompany transfer"

internal reorganization financial

"as part of an internal reorganization of the PPF group of companies"

Joint Filing Agreement regulatory

"have entered into a Joint Filing Agreement dated August 27, 2026"

Power of Attorney regulatory

"Exhibit 99.4 -- Power of Attorney of PPF IM"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

What percentage of Autolus Therapeutics plc (AUTL) does the PPF group report owning in this Schedule 13D/A?

The reporting persons state that PPF IM Ltd. owns 14,782,275 ordinary shares of Autolus Therapeutics plc, representing approximately 5.6% of the outstanding ordinary shares, based on 266,162,540 shares outstanding as of August 10, 2026.

What change is disclosed for AUTL in Amendment No. 11 to the Schedule 13D?

Amendment No. 11 discloses an intercompany transfer of Autolus shares from PPF Biotech B.V. to PPF IM Ltd. as part of an internal reorganization of the PPF group, completed on August 27, 2026. The filing states this did not change ultimate beneficial ownership or control.

Who are the reporting persons in the AUTL Schedule 13D/A filing?

The reporting persons are Renata Kellnerova, AMALAR HOLDING s., PPF Group a.s., and PPF IM Ltd.. PPF IM is the record owner of the shares, wholly owned by PPF Group; Amalar is the majority shareholder of PPF Group; and Mrs. Kellnerova is the majority owner of Amalar.

Did the PPF group indicate any plans to change control of Autolus Therapeutics plc (AUTL)?

No. The reporting persons state the transactions were undertaken solely to effect an internal reorganization, did not change ultimate beneficial ownership or voting/dispositive power, and were not undertaken with any purpose of changing or influencing control of Autolus Therapeutics plc.

Have there been other recent share transactions in AUTL by these reporting persons?

The reporting persons state that, except for the intercompany transfer described, there have been no transactions by them in Autolus ordinary shares during the past 60 days.

How was the price determined for the internal transfer of AUTL shares within the PPF group?

The filing states the shares were transferred internally at a price equal to the closing price of Autolus ordinary shares on the date immediately preceding the applicable date of transfer, using the working capital of PPF IM.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 09:08 PM Accepted by SEC EDGAR 08/28/2026 - 09:08 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 11)

Autolus Therapeutics plc

(Name of Issuer)

ADSs, each representing one ordinary share, nominal value $0.000042 per share, and ordinary shares, nominal value $0.000042 per share

(Title of Class of Securities)

05280R100

(CUSIP Number)

Scott Levi
White & Case LLP, 1221 Avenue of the Americas
New York, NY, 10020-1095
212 819 8320

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/27/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 05280R100

1

Name of reporting person

Renata Kellnerova

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CZECH REPUBLIC

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 14,782,275.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 14,782,275.00

11

Aggregate amount beneficially owned by each reporting person

14,782,275.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.6 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 05280R100

1

Name of reporting person

AMALAR HOLDING s.r.o.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CZECH REPUBLIC

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 14,782,275.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 14,782,275.00

11

Aggregate amount beneficially owned by each reporting person

14,782,275.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.6 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP Number(s): 05280R100

1

Name of reporting person

PPF Group a.s.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CZECH REPUBLIC

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 14,782,275.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 14,782,275.00

11

Aggregate amount beneficially owned by each reporting person

14,782,275.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.6 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP Number(s): 05280R100

1

Name of reporting person

PPF IM Ltd.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF, WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CYPRUS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 14,782,275.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 14,782,275.00

11

Aggregate amount beneficially owned by each reporting person

14,782,275.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.6 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: ADSs, each representing one ordinary share, nominal value $0.000042 per share, and ordinary shares, nominal value $0.000042 per share
(b)	Name of Issuer: Autolus Therapeutics plc
(c)	Address of Issuer's Principal Executive Offices: The Mediaworks, 191 Wood Lane, London, UNITED KINGDOM , W12 7FP.
Item 2.	Identity and Background
(a)	Item 2(a) of the Schedule 13D is hereby amended and restated by replacing it with the following: This Schedule 13D is being filed by the following persons (each a "Reporting Person" and, collectively, the "Reporting Persons"): Renata Kellnerova, a citizen of the Czech Republic; AMALAR HOLDING s.r.o., a limited liability company organized under the laws of the Czech Republic ("Amalar"); PPF Group a.s., a joint stock company organized under the laws of the Czech Republic ("PPF Group"), which is the successor by cross-border conversion to PPF Group N.V., a public limited liability company formerly organized under the laws of the Netherlands; and PPF IM Ltd., a private limited liability company organized and existing under the laws of Cyprus ("PPF IM"). PPF IM is the sole shareholder of record of the Ordinary Shares reported herein. PPF IM is a wholly-owned subsidiary of PPF Group. Amalar is the majority shareholder of PPF Group. Mrs. Kellnerova, in her capacity as the majority owner of Amalar, has the ability to indirectly control the decisions of Amalar regarding the vote and disposition of securities held by Amalar, and as such may be deemed to have indirect beneficial ownership of the Ordinary Shares of the Issuer held by PPF IM. Information regarding each director and officer of PPF IM (collectively, the "Covered Persons") is set forth in the attached Annex A and incorporated by reference. The Reporting Persons have entered into a Joint Filing Agreement dated August 27, 2026, pursuant to Rule 13d-1(k) under the Act, a copy of which is attached hereto as Exhibit 99.1.
(b)	Item 2(b) of the Schedule 13D is hereby amended and restated by replacing it with the following: The principal business address of Mrs. Kellnerova is c/o PPF Group a.s., Evropska 2690/17, 160 00 Prague 6, Czech Republic. The address of the principal office of Amalar is Evropska 2690/17, 160 00 Prague 6, Czech Republic. The address of the principal office of PPF Group is Evropska 2690/17, 160 00 Prague 6, Czech Republic. The address of the principal office of PPF IM is Stasinou, 6, The White Walls, Office 601, 1060 Nicosia, Cyprus. See Item 2(a) above for information regarding the Covered Persons.
(c)	Item 2(c) of the Schedule 13D is hereby amended and restated by replacing it with the following: Mrs. Kellnerova's principal occupation is her position as majority owner of Amalar. The principal business of Amalar is to act as a holding company for certain investments of Mrs. Kellnerova and her daughters. The principal business of PPF Group is investment in multiple market segments such as financial services, telecommunications, media, real estate, marine leisure, e-commerce, mobility and mechanical engineering and biotechnology in Europe, the United States and across Asia. The principal business of PPF IM is to act as a holding company for certain investments of PPF Group. See Item 2(a) above for information regarding the Covered Persons.
(d)	Item 2(d) of the Schedule 13D is hereby amended and restated by replacing it with the following: None of the Reporting Persons, or to the best of their knowledge, any of the Covered Persons, has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	Item 2(e) of the Schedule 13D is hereby amended and restated by replacing it with the following: None of the Reporting Persons, or to the best of their knowledge, any of the Covered Persons, was, during the last five years, a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws.
(f)	Item 2(f) of the Schedule 13D is hereby amended and restated by replacing it with the following: See Item 2(a) above and the cover pages of this Schedule 13D.
Item 3.	Source and Amount of Funds or Other Consideration
	Item 3 of the Schedule 13D is hereby amended and supplemented to include the following: The Ordinary Shares reported herein were transferred by PPF Biotech B.V. to PPF IM by way of an intercompany transfer among affiliated entities under common ultimate ownership and control as part of an internal reorganization of the PPF group of companies. The internal reorganization was completed on August 27, 2026. The shares were transferred internally at a price equal to the closing price of the Ordinary Shares on the date immediately preceding the applicable date of transfer, using the working capital of PPF IM. Otherwise, no funds were expended by PPF IM or PPF Group in connection with the acquisition of beneficial ownership of the Ordinary Shares reported herein as a result of such transfer.
Item 4.	Purpose of Transaction
	Item 4 of the Schedule 13D is hereby amended and supplemented to include the following: The transactions described in this Amendment No. 11 were undertaken solely to effect an internal reorganization of the PPF group of companies. Such transactions did not involve any change in the ultimate beneficial ownership of, or the ultimate voting or dispositive power over, the Ordinary Shares reported herein, and were not undertaken with any purpose of, or with the effect of, changing or influencing control of the Issuer. Other than as described herein, the Reporting Persons do not have any current plans or proposals which relate to or would result in any of the actions described in subparagraphs (a) through (j) above.
Item 5.	Interest in Securities of the Issuer
(a)	Item 5(a) of the Schedule 13D is hereby amended and restated by replacing it with the following: As of the date of this Amendment No. 11, PPF IM is the owner of record of 14,782,275 Ordinary Shares, representing approximately 5.6% of the outstanding Ordinary Shares (based on 266,162,540 shares outstanding as of August 10, 2026, as reported on the Issuer's quarterly report on Form 10-Q filed August 11, 2026). Each Reporting Person, as a result of the relationships described in Item 2, may be deemed to directly or indirectly beneficially own such shares, and each disclaims beneficial ownership except to the extent of its respective pecuniary interest therein.
(b)	Item 5(b) of the Schedule 13D is hereby amended and restated by replacing it with the following: For information on the Reporting Persons' powers to vote and dispose of such shares, see rows 7 to 10 of the cover pages to this Schedule 13D/A.
(c)	Item 5(c) of the Schedule 13D is hereby amended and restated by replacing it with the following: Except for the intercompany transfer of the Ordinary Shares described in Item 2 and Item 3 above, there have been no transactions by the Reporting Persons in the Ordinary Shares effected during the past 60 days.
(d)	Item 5(d) of the Schedule 13D is hereby amended and restated by replacing it with the following: To the best knowledge of the Reporting Persons, no one other than the Reporting Persons and their respective members, shareholders and affiliates has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares reported herein as beneficially owned by the Reporting Persons.
(e)	Item 5(e) of the Schedule 13D is hereby amended and restated by replacing it with the following: Not applicable.
Item 7.	Material to be Filed as Exhibits.
	Item 7 of the Schedule 13D is hereby amended to replace Exhibit 99.1 and to add Exhibit 99.4 as follows: Exhibit 99.1 -- Amended and Restated Joint Filing Agreement. Exhibit 99.4 -- Power of Attorney of PPF IM.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Renata Kellnerova

Signature:	/s/ Lubomir Kral
Name/Title:	Lubomir Kral, Attorney-in-Fact
Date:	08/28/2026

AMALAR HOLDING s.r.o.

Signature:	/s/ Lubomir Kral
Name/Title:	Lubomir Kral, Attorney-in-Fact
Date:	08/28/2026

PPF Group a.s.

Signature:	/s/ Lubomir Kral
Name/Title:	Lubomir Kral, Attorney-in-Fact
Date:	08/28/2026

PPF IM Ltd.

Signature:	/s/ Lubomir Kral
Name/Title:	Lubomir Kral, Attorney-in-Fact
Date:	08/28/2026